1000+ types of tissue microarray

TISSUE ARRAYS

B-110Pro-1

Prostate cancer with hyperplasia tissue array, including TNM, clinical stage, Gleason grade and Gleason scores, 110 cases/110 cores

Zoom

B-110Pro-1

Cores

110

Cases

110

Row number

Column number

Core Diameter(mm)

1.0

Thickness(µm)

5.0

Tissue Array Type

FFPE

Species

Human

QA/QC

H&E and IHC confirmed

Applications

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes

1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Pro

-Prostate

Hyperplasia (*)

Malignant (*)

Malignant (I)

Malignant (II)

Malignant (III)

Malignant (IV)

TISSUE ARRAYS B-110Pro-1

	1	2	3	4	5	6	7	8	9	10
A	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
B	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
C	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
D	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
E	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
F	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
G	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
H	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
I	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
J	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
K	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type
A1	1	70	M	Prostate	Adenocarcinoma 1(3+3)	*	T3N0M0	III	Malignant
A2	2	79	M	Prostate	Adenocarcinoma 1(3+3)	*	*	*	Malignant
A3	3	69	M	Prostate	Adenocarcinoma 1(3+3) (sparse)	*	*	*	Malignant
A4	4	73	M	Prostate	Adenocarcinoma 1(3+3)	*	*	*	Malignant
A5	5	68	M	Prostate	Adenocarcinoma 1(3+3)	*	T3N0M0	III	Malignant
A6	6	67	M	Prostate	Adenocarcinoma 2(3+4)	*	T2bN0M0	II	Malignant
A7	7	56	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant
A8	8	70	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant
A9	9	65	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant
A10	10	64	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant
B1	11	84	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant
B2	12	72	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant
B3	13	68	M	Prostate	Adenocarcinoma 2(3+4) (sparse)	*	*	*	Malignant
B4	14	73	M	Prostate	Adenocarcinoma 3(4+3)	*	T1N0M0	I	Malignant
B5	15	64	M	Prostate	Adenocarcinoma 1(3+3)	*	*	*	Malignant
B6	16	71	M	Prostate	Adenocarcinoma 2(3+4)	*	T3N0M0	III	Malignant
B7	17	75	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant
B8	18	57	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant
B9	19	71	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant
B10	20	66	M	Prostate	Adenocarcinoma 2(3+4)	*	T2aN0M0	II	Malignant
C1	21	64	M	Prostate	Adenocarcinoma 3(4+3)	*	T2N0M0	II	Malignant
C2	22	60	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant
C3	23	72	M	Prostate	Adenocarcinoma 3(4+3) (interstitial)	*	T2N0M0	II	Malignant
C4	24	62	M	Prostate	Adenocarcinoma 3(4+3)	*	T3N1M0	IV	Malignant
C5	25	64	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant
C6	26	73	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant
C7	27	75	M	Prostate	Adenocarcinoma 3(4+3)	*	T3N0M0	III	Malignant
C8	28	65	M	Prostate	Adenocarcinoma 3(4+3)	*	T2aN0M0	I	Malignant
C9	29	69	M	Prostate	Adenocarcinoma 4(3+5)	*	T3N0M0	III	Malignant
C10	30	78	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant
D1	31	82	M	Prostate	Adenocarcinoma 4(4+4)	*	T2aN0M0	II	Malignant
D2	32	71	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D3	33	72	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D4	34	91	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D5	35	62	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D6	36	70	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D7	37	62	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant
D8	38	20	M	Prostate	Adenocarcinoma 4(4+4)	*	T2aN0M0	II	Malignant
D9	39	66	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
D10	40	61	M	Prostate	Adenocarcinoma 4(4+4)	*	T3N0M0	III	Malignant
E1	41	62	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	I	Malignant
E2	42	69	M	Prostate	Adenocarcinoma 4(4+4)	*	T3N1M0	IV	Malignant
E3	43	72	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant
E4	44	69	M	Prostate	Adenocarcinoma 4(3+5)	*	T3N0M0	III	Malignant
E5	45	75	M	Prostate	Adenocarcinoma 4(5+3)	*	*	*	Malignant
E6	46	71	M	Prostate	Adenocarcinoma 4(5+3)	*	*	*	Malignant
E7	47	64	M	Prostate	Adenocarcinoma 4(5+3)	*	T2N0M0	II	Malignant
E8	48	78	M	Prostate	Adenocarcinoma 5(4+5) (interstitial)	*	*	*	Malignant
E9	49	78	M	Prostate	Adenocarcinoma with necrosis 5(4+5)	*	*	*	Malignant
E10	50	79	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant
F1	51	72	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant
F2	52	81	M	Prostate	Adenocarcinoma with necrosis 5(4+5)	*	*	*	Malignant
F3	53	75	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant
F4	54	76	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant
F5	55	87	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant
F6	56	74	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant
F7	57	72	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant
F8	58	70	M	Prostate	Adenocarcinoma 5(4+5)	*	T3N0M0	III	Malignant
F9	59	66	M	Prostate	Adenocarcinoma 5(4+5)	*	T3aN0M0	III	Malignant
F10	60	81	M	Prostate	Adenocarcinoma 5(4+5)	*	T3aN0M0	III	Malignant
G1	61	68	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
G2	62	69	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
G3	63	76	M	Prostate	Adenocarcinoma 5(5+5)	*	*	*	Malignant
G4	64	85	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
G5	65	67	M	Prostate	Adenocarcinoma 4(5+3)	*	*	*	Malignant
G6	66	85	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
G7	67	64	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant
G8	68	74	M	Prostate	Adenocarcinoma 5(5+4) (sparse)	*	*	*	Malignant
G9	69	77	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
G10	70	83	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant
H1	71	76	M	Prostate	Adenocarcinoma 5(5+4)	*	T3N0M0	III	Malignant
H2	72	64	M	Prostate	Adenocarcinoma 5(5+4) (sparse)	*	T3N0M0	III	Malignant
H3	73	65	M	Prostate	Adenocarcinoma 5(5+4)	*	T2N0M0	II	Malignant
H4	74	65	M	Prostate	Adenocarcinoma 5(5+4)	*	T2N0M0	II	Malignant
H5	75	60	M	Prostate	Adenocarcinoma 5(5+4)	*	T3aN0M0	III	Malignant
H6	76	65	M	Prostate	Adenocarcinoma 5(5+4)	*	T2aN0M0	II	Malignant
H7	77	82	M	Prostate	Adenocarcinoma 5(5+4) (interstitial)	*	T2N0M0	II	Malignant
H8	78	80	M	Prostate	Adenocarcinoma 5(5+4)	*	T3N0M0	III	Malignant
H9	79	63	M	Prostate	Adenocarcinoma 5(5+4)	*	T2N0M0	II	Malignant
H10	80	56	M	Prostate	Adenocarcinoma 5(5+4)	*	T3N0M0	III	Malignant
I1	81	72	M	Prostate	Adenocarcinoma 5(5+5) (interstitial)	*	T3N0M0	III	Malignant
I2	82	34	M	Prostate	Adenocarcinoma 5(5+5)	*	T2bN0M0	II	Malignant
I3	83	62	M	Prostate	Adenocarcinoma 5(5+5)	*	T2bN0M0	II	Malignant
I4	84	64	M	Prostate	Adenocarcinoma 5(5+5)	*	T2bN0M0	II	Malignant
I5	85	60	M	Prostate	Adenocarcinoma 5(5+5)	*	T3N0M0	III	Malignant
I6	86	76	M	Prostate	Adenocarcinoma with necrosis 5(5+5)	*	T2N0M0	II	Malignant
I7	87	81	M	Prostate	Adenocarcinoma 5(5+5)	*	*	*	Malignant
I8	88	75	M	Prostate	Adenocarcinoma	*	T2N0M0	II	Malignant
I9	89	60	M	Prostate	Adenocarcinoma 5(5+5)	*	*	*	Malignant
I10	90	60	M	Prostate	Adenocarcinoma 5(5+5)	*	T2N0M0	II	Malignant
J1	91	84	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J2	92	63	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J3	93	65	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J4	94	78	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J5	95	70	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J6	96	70	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J7	97	68	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J8	98	88	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J9	99	64	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
J10	100	48	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K1	101	80	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K2	102	72	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K3	103	82	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K4	104	69	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K5	105	71	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K6	106	68	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K7	107	80	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K8	108	68	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K9	109	71	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
K10	110	86	M	Prostate	Hyperplasia	*	*	*	Hyperplasia
Tissue Marker